Showing results (1-10 of 145) with videos related to
Sort By:
Pageof 15
Cancer Letters|September 25, 1995
Tubercidin stabilizes microtubules against vinblastine-induced depolymerization, a taxol-like effectS L Mooberry, K Stratman, R E MooreJournal of Natural Products|June 8, 2000
Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majusculaH Luesch, W Y Yoshida, R E Moore, et al.Cancer Research|July 15, 1994
Cryptophycin: a new antimicrotubule agent active against drug-resistant cellsC D Smith, X Zhang, S L Mooberry, et al.Journal of Natural Products|July 28, 2001
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1H Luesch, R E Moore, V J Paul, et al.Cancer Letters|May 19, 1998
Monoclonal antibodies to taxanes that neutralize the biological activity of paclitaxelG S Bignami, S L MooberryBiochemistry International|March 1, 1992
The protein kinase inhibitor, staurosporine, does not inhibit phosphoinositide kinasesC D Smith, S L MooberryStudies in Human Ecology|January 1, 1992
Gross motor skills in Navajo American Indian children one year or underS K StratmanInternational Journal of Cancer|November 14, 1997
Induction of apoptosis by cryptophycin 1, a new antimicrotubule agentS L Mooberry, L Busquets, G TienCancer Letters|October 1, 1996
Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding siteS L Mooberry, C R Taoka, L BusquetsJournal of Natural Products|September 28, 1998
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.Pageof 15